KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - AccuredRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Twist Bioscience (TWST) Work In Process (2018 - 2025)

Twist Bioscience (TWST) has disclosed Work In Process for 6 consecutive years, with $611000.0 as the latest value for Q2 2023.

  • On a quarterly basis, Work In Process fell 84.25% to $611000.0 in Q2 2023 year-over-year; TTM through Jun 2023 was $611000.0, a 84.25% decrease, with the full-year FY2022 number at $100000.0, down 97.93% from a year prior.
  • Work In Process was $611000.0 for Q2 2023 at Twist Bioscience, down from $1.0 million in the prior quarter.
  • In the past five years, Work In Process ranged from a high of $4.8 million in Q3 2021 to a low of $100000.0 in Q3 2022.
  • A 5-year average of $1.9 million and a median of $1.7 million in 2020 define the central range for Work In Process.
  • Peak YoY movement for Work In Process: skyrocketed 139.34% in 2021, then tumbled 97.93% in 2022.
  • Twist Bioscience's Work In Process stood at $1.2 million in 2019, then surged by 47.02% to $1.7 million in 2020, then surged by 84.77% to $3.1 million in 2021, then crashed by 96.82% to $100000.0 in 2022, then skyrocketed by 511.0% to $611000.0 in 2023.
  • Per Business Quant, the three most recent readings for TWST's Work In Process are $611000.0 (Q2 2023), $1.0 million (Q1 2023), and $100000.0 (Q3 2022).